Want to join the conversation?
Biotechnology and clinical diagnostic brands holding company $TECH said it will acquire Advanced Cell Diagnostics (ACD) for $250MM in cash plus contingent consideration of $75MM due upon achieving some milestones. Deal will be financed through cash on hand and a revolving credit facility that $TECH expects to obtain before closing the acquisition.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.